logo

For the Inventor, By the Inventor

Edinburgh, United Kingdom

Robert L Jones

This inventor holds 13 USPTO granted patents. Top assignee: National Research Development Corporation. Active years: 1983-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert L Jones. Retrieved from https://idiyas.com/inventor/robert-l-jones-ity4m95m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 6

Forward Citations = 71(Granted Patents)


Company Filing History:

goldMedal13 out of 1,200 
 
National Research Development Corporation
 patents

Years Active: 1983-1992

Loading Chart...
13 patents (USPTO):Explore Patents
1. 5081282 - Prostaglandins (1992-01-14),
2. 5077309 - Prostaglandins (1991-12-31),
3. 5028733 - Prostaglandins (1991-07-02),
4. 5025034 - Prostaglandins (1991-06-18),
5. 5006539 - Prostaglandins (1991-04-09),
6. 4945106 - Prostaglandins (1990-07-31),
7. 4837234 - Prostaglandins (1989-06-06),
8. 4628061 - Prostaglandins (1986-12-09),
9. 4596823 - Prostaglandins (1986-06-24),
10. 4458091 - Prostaglandins (1984-07-03),
11. 4438136 - Prostaglandins (1984-03-20),
12. 4430345 - Prostaglandins (1984-02-07),
13. 4368332 - Prostaglandins (1983-01-11),

Title: The Innovative Path of Robert L Jones: Revolutionizing Healthcare through Prostaglandins

Introduction: Robert L Jones, a brilliant inventor hailing from Edinburgh, United Kingdom, has left an indelible mark on the field of pharmaceuticals with his remarkable contributions. With an impressive total of 13 patents to his name, Jones is renowned for his groundbreaking work in the development of prostaglandins.

Latest Patents: Jones' latest patents showcase his pioneering spirit in the realm of pharmaceuticals. He has successfully synthesized a new class of compounds with the formula (I) that have shown significant potential in inhibiting thromboxane activity. These compounds hold immense promise for incorporation into pharmaceutical compositions, particularly in the healthcare sector.

Career Highlights: Jones is associated with the prestigious National Research Development Corporation, where he has had the opportunity to harness his inventive prowess to drive impactful innovations. His journey as an inventor has been characterized by a relentless pursuit of excellence and a deep commitment to pushing the boundaries of scientific exploration.

Collaborations: Throughout his career, Jones has had the privilege of collaborating with esteemed professionals in the field. One such notable coworker is Norman H Wilson, who has played a pivotal role in shaping Jones' innovative endeavors. Together, they have synergized their expertise to delve into cutting-edge research and development activities.

Conclusion: Robert L Jones stands as a testament to the power of relentless innovation and unwavering dedication in the realm of pharmaceutical inventions. His remarkable contributions in the synthesis of prostaglandins underscore his commitment to advancing healthcare solutions. As Jones continues to pave the way for future breakthroughs, his legacy as a visionary inventor remains firmly etched in the annals of scientific history.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…